跳至主要内容
临床试验/NCT05276778
NCT05276778已完成不适用

Diabetic Retinopathy Screenings in General Practice for People With Type 2 Diabetes

Aalborg University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Patients' acceptance of diabetic retinopathy screenings in general practice

研究概览

简要总结

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.

The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with type 2 diabetes
  • Understands Danish
  • Age between 18-70

排除标准

  • Blindness
  • Cannot partake in second screening

结局指标

主要结局

Patients' acceptance of diabetic retinopathy screenings in general practice

时间窗: 1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)

Questionnaire

次要结局

未报告次要终点

研究者

发起方
Aalborg University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Malene Krogh

Ph.D. student

Aalborg University

研究点 (1)

Loading locations...

相似试验